Patients taking narrow therapeutic index drugs may require monitoring because small differences in blood concentration could cause:

Drug-disease contraindications refer to situations where a drug should not be used due to the presence of a specific disease or condition. While contraindications are important to consider, they are not directly related to the concentration levels of NTI drugs. Instead, contraindications are based on patient health conditions and risk factors, rather than the pharmacokinetics of the drug itself.

Chemical incompatibilities involve interactions between drugs that can lead to adverse reactions when they are mixed or administered together. This concept does not pertain to the blood concentration levels of NTI drugs, but rather to how different substances interact chemically. Therefore, chemical incompatibilities are unrelated to the specific need for monitoring NTI drugs based on their therapeutic index.

Anaphylactic shock is a severe allergic reaction that can occur in response to certain drugs, but it is not directly related to the concentration of NTI drugs. This reaction is an immune response rather than a consequence of blood concentration variability. Monitoring NTI drugs is primarily concerned with avoiding toxic effects due to concentration changes, rather than managing allergic reactions.